3 ASX stocks every Aussie investor should consider in 2026

These are my top picks!

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a subdued start to the year for ASX stocks. The S&P/ASX 300 Index (ASX: XKO) is 1.57% higher for the year-to-date, and the S&P/ASX 200 Index (ASX: XJO) is up 1.62% as cost-of-living pressures, cash rate hike concerns and market shifts weigh on investor sentiment.

In times like these, it's important for investors to see the forest through the trees and identify investment opportunities amid market ups and downs.

Here are three ASX stocks I think every Aussie investor should consider for their portfolio this year.

Three happy office workers cheer as they read about good financial news on a laptop.

Image source: Getty Images

Electro Optic Systems Holdings Ltd (ASX: EOS)

EOS is a red-hot Aussie defence stock that develops and produces advanced electro-optic technologies. For the year-to-date, the company's shares are down 8.44%, and while this isn't ideal, in the context of its enormous 646.72% annual gain, it's not too alarming.

The ASX stock has benefited from surging demand for exposure to the defence sector amid ongoing geopolitical volatility. Recent data shows that Global military spending reached an unprecedented US$2.7 trillion in 2024. I'd bet the figure was even higher for 2025.

The company has had several major contract wins recently and is well-positioned for strong growth this year. 

Analysts rate the shares a strong buy and tip an upside of up to 40.24% to $12.72 at the time of writing.

Telix Pharmaceuticals Ltd (ASX: TLX)

Telix shares are down 2.51% to $11.08 a piece for the year-to-date, at the time of writing. Thanks to several significant headwinds over the past year, they're now down 61.43% year-on-year.

Its recent Q4 FY25 results disappointed investors, despite the biotech stock reporting that it achieved its US$804 million FY25 guidance. Over the past few months, the company has also had regulatory filing issues with the US Food and Drug Administration.

But I think Telix still has exceptional growth potential amid a rapidly growing market, and at the current share price, in my view, the ASX stock is a buy.

Analysts mostly rate the shares as a strong buy and predict they could soar by up to 203.92% this year to $33.69 at the time of writing. 

BHP Group Ltd (ASX: BHP)

The mining giant recently took the reins as the largest stock on the Australian sharemarket. BHP shares crossed the $50 mark earlier this week, pushing the miner's market capitalisation to just over $253.5 billion. Commonwealth Bank of Australia (ASX: CBA) is now in second place, with a market capitalisation of around $251.9 billion.

At the time of writing, the miner's shares are down 0.85% to $50.17, although they're 9.65% higher for the year-to-date and 28.23% higher than this time last year.

Analysts' forecasts for the stock's direction from here are subdued, with most holding a neutral stance and some even expecting a slight downside. 

But unlike the two ASX stocks listed above, I think BHP shares should be considered this year for more than just the upside potential. It's worth noting that the company's production is growing, and the business is diverse and actively expanding. And, of course, the miner offers a strong passive income stream for investors seeking reliable cash flow. 

Over the past 12 months, BHP paid an interim dividend of 79.1 cents per share on 27 March and a final dividend of 91.9 cents per share on 25 September, both fully franked. That's a full-year passive income payout of $1.71 per share.

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems and Telix Pharmaceuticals. The Motley Fool Australia has recommended BHP Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Happy couple doing online shopping.
Opinions

Down 17%: Why I'd buy and hold Wesfarmers shares

Bunnings remains the key asset, but I think Wesfarmers has more than one way to create value over time.

Read more »

Opinions

2 top ASX shares to buy and hold for the next decade

I’m backing these investments to deliver big returns!

Read more »

Four girls in festive pink hats are sitting on a hammock and laughing merrily.
Opinions

4 ASX 200 shares I'd buy with $5,000 in June

One of the ASX 200 shares is tipped to climb another 169%!

Read more »

A boy standing on the edge of a cliff peers at a red flag in the distance through binoculars.
Opinions

Brambles shares have been smashed. Is this the support level to watch?

Investors are watching one level after Brambles’ heavy fall.

Read more »

Animated man balancing on a chart with a red and green arrow symbolising volatility.
Opinions

How to invest in ASX shares during such an uncertain period

Uncertainty can make it harder to invest. I won’t let market fear stop me...

Read more »

Woman holding $50 and $20 notes.
Dividend Investing

2 excellent high-yield ASX dividend stocks I'd buy today

These businesses offer excellent passive income.

Read more »

A male doctor wearing a white lab coat shrugs his shoulders and holds his hands up in the air looking confused
Healthcare Shares

Should I buy CSL shares in June?

Here's what I expect from the beaten-down biotech stock next month.

Read more »

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer
Best Shares

Screaming buys: My top 5 favourite stocks in the world

I don't think you can get better than these five stocks.

Read more »